Registry and Prevalence of Gene Mutation in Korean Patients With Familial Hypertrophic Cardiomyopathy

Brief Title

Registry and Prevalence of Gene Mutation in Korean Patients With Familial Hypertrophic Cardiomyopathy


Brief Summary

      Set the Korean Familial Hypertrophic Cardiomyopathy (KFHC) registry to study the prevalence
      of gene mutations in Korean patients with familial hypertrophic cardiomyopathy
    



Study Type

Observational [Patient Registry]


Primary Outcome

1) DNA analysis

Secondary Outcome

 2) Prognosis of familial hypertrophic cariomyopathy

Condition

Familial Hypertrophic Cardiomyopathy


Study Arms / Comparison Groups

 familial hypertrophic cardiomyopathy
Description:  familial hypertrophic cardiomyopathy patients and their relatives

Publications

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information



Estimated Enrollment

99

Start Date

February 2013

Completion Date

August 2013

Primary Completion Date

August 2013

Eligibility Criteria

        Inclusion Criteria:

          1. left ventricular maximal wall thickness ≥ 15mm on echocardiography

          2. hypertrophic cardiomyopathy patients' relatives

        Exclusion Criteria:

          1. other cardiomyopathy or systemic disease (e.g. fabry disease, danon disease, glycogen
             storage disease)

          2. who deny the study entrance, especially in patients' relatives
      

Gender

All

Ages

13 Years - N/A

Accepts Healthy Volunteers

No

Contacts

, , 

Location Countries

Korea, Republic of

Location Countries

Korea, Republic of

Administrative Informations


NCT ID

NCT01792960

Organization ID

4-2012-0869


Responsible Party

Sponsor

Study Sponsor

Yonsei University


Study Sponsor

, , 


Verification Date

February 2014